Article Versions Notes

De Caterina R, Kim Y-H, Koretsune Y, Wang C-C, Yamashita T, Chen C, Reimitz P-E, Unverdorben M, Kirchhof P. Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program. Journal of Clinical Medicine. 2021; 10(4):573. https://doi.org/10.3390/jcm10040573

De Caterina, Raffaele, Young-Hoon Kim, Yukihiro Koretsune, Chun-Chieh Wang, Takeshi Yamashita, Cathy Chen, Paul-Egbert Reimitz, Martin Unverdorben, and Paulus Kirchhof. 2021. "Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program" Journal of Clinical Medicine 10, no. 4: 573. https://doi.org/10.3390/jcm10040573

De Caterina, R., Kim, Y. -H., Koretsune, Y., Wang, C. -C., Yamashita, T., Chen, C., Reimitz, P. -E., Unverdorben, M., & Kirchhof, P. (2021). Safety and Effectiveness of Edoxaban in Atrial Fibrillation Patients in Routine Clinical Practice: One-Year Follow-Up from the Global Noninterventional ETNA-AF Program. Journal of Clinical Medicine, 10(4), 573. https://doi.org/10.3390/jcm10040573